|
1 |
19 10 2026 |
Pharmexcil explores export opportunities for Indian pharma and medical device companies in Argentina |
Pharmabiz |
India |
|
2 |
19 10 2026 |
Telangana: Anti-Pharma City committee alleges forcible land acquisition |
New Indian Express |
India |
|
3 |
19 10 2026 |
Pharma PLI scheme enables domestic production of 1,931 products, including 191 bulk drugs for the first time |
Pharmabiz |
India |
|
4 |
19 10 2026 |
Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27 |
Pharmabiz |
India |
|
5 |
19 10 2026 |
DoP asks industry for timely submission of complete documents to process RPTUAS applications expeditiously |
Pharmabiz |
India |
|
6 |
19 10 2026 |
FSDA cancels licences of 14 medicine firms in Aminabad |
Health World(Economic Times) |
India |
|
7 |
17 10 2026 |
NPPA issues Rs.52.75 crore demand notice to Akums Drug susbsidiary Hetro , Abaris over Lanol injection |
Medical Dialogues |
India |
|
8 |
17 10 2026 |
Mankind Pharma to acquire 70% stake in Armed cell Therapeutics for Rs.511.4 crore |
Medical Dialogues |
India |
|
9 |
17 10 2026 |
Laurus Labs invest Rs.107.8 crore in KRKA Pharma through rights issues |
Medical Dialogues |
India |
|
10 |
17 10 2026 |
137 cancer drugs including Pembrolizumab , Osimertinib to get cheaper prices may drop up to 70% |
Medical Dialogues |
India |
|
11 |
17 10 2026 |
Approved r-DNA drug need No separate exort NOC for brand name change : CDSCO |
Medical Dialogues |
India |
|
12 |
17 10 2026 |
India's Vins Bioproducts , Germany's Neovii Biotech to collaborate on immunoglobulin manufacturing |
Medical Dialogues |
United Kingdom |
|
13 |
17 10 2026 |
Telangana DCA issues strict warning against online sale of unapproved weight-loss drugs and peptides |
Pharmabiz |
India |
|
14 |
17 10 2026 |
DGFT amends export policy for prepared culture media to facilitate pharma export compliance |
Pharmabiz |
India |
|
15 |
16 10 2026 |
IDMA asks pharma companies to submit UCPMP marketing expenditure disclosures for FY26 |
Pharmabiz |
India |
|
16 |
16 10 2026 |
Approved r-DNA products shall not require separate export NOC, subject to conditions: CDSCO |
Pharmabiz |
India |
|
17 |
16 10 2026 |
Zydus Sunshine Lifesciences to invest over USD 20 Million in Sri Lanka Pharma manufacturing facility |
Pharmabiz |
India |
|
18 |
16 10 2026 |
Mankind Pharma to acquire 70% in Belgian biotech firm for €48 million |
Business Standard |
India |
|
19 |
15 10 2026 |
India’s pharmacy sector strengthens focus on affordable, uninterrupted medicine supply |
Pharmabiz |
India |
|
20 |
15 10 2026 |
Successful quality organisation in pharma must do more than demonstrate compliance: Subhrangshu Chaudhury |
Health World(Economic Times) |
India |
